Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab
Cancer Res. (2004) - Comments

Ali R Jazirehi, Mario I Vega, Devasis Chatterjee, Lee Goodglick, Benjamin Bonavida